The International Journal of Biological Markers · 1989 · 10 citations · 4 references
MedicineOncologyOtolaryngologyCancer ImmunologyMolecular OncologyTumor ImmunologyCancer Molecular DiagnosticsMalignant NeoplasmsSquamous Cell CarcinomaTumor AntigensTumor MarkersTumor-associated AntigensEarly Cancer Detection MarkersImmunoassay BiomarkersTumor Antigen Identification
Five tumor markers (CEA, Ferritin, CA-50, TPA and SCC) were assayed in 54 patients with ear, nose and throat (ENT) cancers in early and advanced stages. The specificity of these markers always exceeded 95%. Their sensitivity ranged from 13 to 43%, and reached 72% as a combination of all five markers. No distinction was found between early and advanced stage of illness. These markers seem to have no distinct function in ENT oncological diagnosis and follow-up because objective data is easily available even in early tumors.
4
Continuous cultures of fused cells secreting antibody of predefined specificity
Georges Köhler, César Milstein · Nature · 1975 · 17.2K citations
Pharmacy, Cell Biology, Immunology +11
Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer
Hiroshi Kato, Hitoshi Morioka, Haruyo Tsutsui et al. · Cancer · 1982 · 104 citations · Full text
CEA levels in head and neck cancer
Norman A. Silverman, John C. Alexander, Paul B. Chretien · Cancer · 1976 · 95 citations · Full text